Concepedia

Publication | Closed Access

Preclinical comparison of the blood brain barrier (BBB) permeability of osimertinib (AZD9291) with other irreversible next generation EGFR TKIs

DOI

22

Citations

0

References

2016

Year

Nicola Colclough, Pete G. Ballard, Peter Barton, K. Chen, Darren A.E. Cross, M. Raymond V. Finlay, Lili Han, Annika Janefeldt, Peter Johnström, Richard A. Ward,
European Journal of Cancer

No additional data available for this publication yet. Check back later!